-+ 0.00%
-+ 0.00%
-+ 0.00%

Lake Street Initiates Coverage On Connect Biopharma Hldgs with Buy Rating, Announces Price Target of $9

Benzinga·12/01/2025 17:01:19
Listen to the news
Lake Street analyst Thomas Flaten initiates coverage on Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy rating and announces Price Target of $9.